Lingjun Zhu
- Molecular Biology top 5%
- Cancer Research top 1%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Immunology top 10%
- Topics
- Cancer-related molecular mechanisms research (18 papers)RNA modifications and cancer (15 papers)Cancer Genomics and Diagnostics (14 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Lingjun Zhu
98 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Molecular Biology 1.7k
- Cancer Research 1.2k
- Oncology 618
- Pulmonary and Respiratory Medicine 284
- Immunology 262
Countries citing papers authored by Lingjun Zhu
This map shows the geographic impact of Lingjun Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingjun Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingjun Zhu more than expected).
Fields of papers citing papers by Lingjun Zhu
This network shows the impact of papers produced by Lingjun Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingjun Zhu. The network helps show where Lingjun Zhu may publish in the future.
Co-authorship network of co-authors of Lingjun Zhu
This figure shows the co-authorship network connecting the top 25 collaborators of Lingjun Zhu. A scholar is included among the top collaborators of Lingjun Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingjun Zhu. Lingjun Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 10 | |
| 3 | 1 | |
| 4 | Exosomal circLPAR1 functions in colorectal cancer diagnosis and tumorigenesis through suppressing BRD4 via METTL3–eIF3h interactionbreakdown → | 158 |
| 5 | 2 | |
| 6 | Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironmentbreakdown → | 223 |
| 7 | 2 | |
| 8 | 3 | |
| 9 | 18 | |
| 10 | 42 | |
| 11 | 24 | |
| 12 | 6 | |
| 13 | 17 | |
| 14 | 18 | |
| 15 | 14 | |
| 16 | 10 | |
| 17 | 56 | |
| 18 | 50 | |
| 19 | 7 | |
| 20 | 63 |
About Lingjun Zhu
Lingjun Zhu is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 101 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (18 papers), RNA modifications and cancer (15 papers) and Cancer Genomics and Diagnostics (14 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (1.7k citations) and Oncology (618 citations). Lingjun Zhu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Meilin Wang, Haiyan Chu, Dongying Gu, Mulong Du, Zhengdong Zhang, Yongqian Shu, Na Tong, Jinfei Chen, Shuwei Li and Ling Ma. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.